Skip to main content
logo
Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
30.81
-0.37 (-1.19%)
At close: Jul 24, 2026, 4:00 PM EDT
30.91
+0.10 (0.31%)
After-hours: Jul 24, 2026, 7:34 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue from Sale of Goods
14.60B14.61B14.05B
Licensing Arrangements Revenue
681.00M678.00M173.00M
Distribution Revenue
1.56B1.55B1.58B
Other Segment Revenue
504.00M423.00M745.00M
Revenue (Other)
1.00M1.00M-
Revenue (Total)
17.35B17.26B16.54B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States Revenue
8.81B9.19B8.03B
Europe Revenue
5.19B5.04B5.10B
International Markets Revenue
2.10B2.16B2.46B
Other Activities Revenue
1.25B870.00M944.00M
Revenue (Total)
17.35B17.26B16.54B

Adjusted EBIT by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States Segment Profit
3.33B3.36B2.30B
Europe Segment Profit
1.38B1.30B1.58B
International Markets Segment Profit
304.00M336.00M440.00M
Other Activities Segment Profit
-93.00M-90.00M18.00M
Operating Income (Total)
2.29B2.16B-303.00M